Today news
About the same in other media
Tether Invests $200 Million in Blackrock Neurotech’s Neurological Disorder Solutions
Reading now: 749
Tether, the issuer of the USDT stablecoin, has made a groundbreaking move in the healthcare sector with a strategic $200 million investment in Blackrock Neurotech, a leading biotech company specializing in brain-computer interface (BCI) technology.
Through its new venture division , Tether Evo, the stablecoin giant, has become the majority stakeholder in Blackrock Neurotech, signaling a significant step towards advancing medical solutions for individuals affected by paralysis, neurological disorders, and lost function.
Today Tether takes the majority stake in @BlackrockNeuro_ and unveils the ultimate pillar of its long term vision and strategy: Tether Evo
Read more on cryptonews.comAbout this in other media
Wells Fargo Banks Has Invested $143 Million In Bitcoin, Filing Reveals cryptonews.com /5 days ago
Stablecoin Issuer Tether Hits Back Deutsche Bank’s Argument Over its Solvency cryptonews.com /5 days ago
Tether Boosts Crypto Payments in Eastern Europe with Investment in CityPay.io cryptonews.com /6 days ago
Show more
The website gocryptonft.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
